Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 56% ± 22% | |
peripheral blood | 17 studies | 30% ± 13% | |
lung | 13 studies | 27% ± 10% | |
eye | 10 studies | 35% ± 17% | |
heart | 5 studies | 30% ± 9% | |
kidney | 5 studies | 25% ± 5% | |
liver | 5 studies | 34% ± 9% | |
bone marrow | 4 studies | 29% ± 8% | |
lymph node | 4 studies | 24% ± 5% | |
breast | 4 studies | 22% ± 7% | |
adipose | 4 studies | 42% ± 11% | |
pancreas | 3 studies | 33% ± 18% | |
intestine | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5659.83 | 1444 / 1445 | 100% | 21.77 | 183 / 183 |
thymus | 100% | 5455.46 | 653 / 653 | 98% | 13.26 | 594 / 605 |
breast | 100% | 8792.26 | 459 / 459 | 98% | 16.04 | 1091 / 1118 |
intestine | 99% | 5002.01 | 961 / 966 | 98% | 11.24 | 515 / 527 |
lung | 99% | 5197.08 | 575 / 578 | 97% | 12.77 | 1125 / 1155 |
prostate | 100% | 4694.62 | 245 / 245 | 97% | 13.77 | 486 / 502 |
stomach | 99% | 3459.83 | 355 / 359 | 98% | 13.15 | 280 / 286 |
brain | 97% | 7005.44 | 2572 / 2642 | 99% | 17.80 | 701 / 705 |
skin | 100% | 11523.76 | 1809 / 1809 | 96% | 15.17 | 452 / 472 |
bladder | 100% | 5460.29 | 21 / 21 | 96% | 10.87 | 482 / 504 |
uterus | 100% | 5806.99 | 170 / 170 | 95% | 12.23 | 438 / 459 |
pancreas | 96% | 2791.37 | 315 / 328 | 98% | 11.60 | 175 / 178 |
ovary | 100% | 7661.90 | 180 / 180 | 90% | 6.59 | 387 / 430 |
kidney | 98% | 2984.33 | 87 / 89 | 92% | 10.49 | 830 / 901 |
adrenal gland | 99% | 3767.55 | 256 / 258 | 89% | 10.80 | 204 / 230 |
liver | 81% | 1591.73 | 182 / 226 | 52% | 2.85 | 211 / 406 |
adipose | 100% | 10707.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7799.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.32 | 29 / 29 |
spleen | 100% | 7972.22 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 3302.46 | 793 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.72 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 93% | 10.50 | 74 / 80 |
heart | 89% | 3220.09 | 762 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 4510.35 | 551 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0016567 | Biological process | protein ubiquitination |
GO_0051493 | Biological process | regulation of cytoskeleton organization |
GO_0032880 | Biological process | regulation of protein localization |
GO_0050905 | Biological process | neuromuscular process |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_1902667 | Biological process | regulation of axon guidance |
GO_0021785 | Biological process | branchiomotor neuron axon guidance |
GO_0021952 | Biological process | central nervous system projection neuron axonogenesis |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0008582 | Biological process | regulation of synaptic assembly at neuromuscular junction |
GO_0007411 | Biological process | axon guidance |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030424 | Cellular component | axon |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MYCBP2 |
Protein name | MYC binding protein 2 RCR-type E3 ubiquitin transferase (EC 2.3.2.33) E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc) |
Synonyms | PAM KIAA0916 |
Description | FUNCTION: Atypical E3 ubiquitin-protein ligase which specifically mediates ubiquitination of threonine and serine residues on target proteins, instead of ubiquitinating lysine residues . Shows esterification activity towards both threonine and serine, with a preference for threonine, and acts via two essential catalytic cysteine residues that relay ubiquitin to its substrate via thioester intermediates . Interacts with the E2 enzymes UBE2D1, UBE2D3, UBE2E1 and UBE2L3 . Plays a key role in neural development, probably by mediating ubiquitination of threonine residues on target proteins (Probable). Involved in different processes such as regulation of neurite outgrowth, synaptic growth, synaptogenesis and axon degeneration (By similarity). Required for the formation of major central nervous system axon tracts (By similarity). Required for proper axon growth by regulating axon navigation and axon branching: acts by regulating the subcellular location and stability of MAP3K12/DLK (By similarity). Required for proper localization of retinogeniculate projections but not for eye-specific segregation (By similarity). Regulates axon guidance in the olfactory system (By similarity). Involved in Wallerian axon degeneration, an evolutionarily conserved process that drives the loss of damaged axons: acts by promoting destabilization of NMNAT2, probably via ubiquitination of NMNAT2 (By similarity). Catalyzes ubiquitination of threonine and/or serine residues on NMNAT2, consequences of threonine and/or serine ubiquitination are however unknown . Regulates the internalization of TRPV1 in peripheral sensory neurons (By similarity). Mediates ubiquitination and subsequent proteasomal degradation of TSC2/tuberin . Independently of the E3 ubiquitin-protein ligase activity, also acts as a guanosine exchange factor (GEF) for RAN in neurons of dorsal root ganglia . May function as a facilitator or regulator of transcriptional activation by MYC . Acts in concert with HUWE1 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 . . |
Accessions | A0A8Q3SHQ2 ENST00000695079.1 ENST00000357337.11 A0A804HJ25 A0A8Q3SHK7 ENST00000544440.7 [O75592-1] A0A804HKQ1 ENST00000695080.1 ENST00000684354.1 A0A8Q3SHQ6 ENST00000682321.1 O75592 ENST00000683823.1 ENST00000429715.1 ENST00000683697.1 A0A499FJI4 A0A804HL12 H7C3U4 A0A804HIR9 ENST00000695081.1 |